Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.1B | 5.5B | 5.3B | 5.3B |
Cost of revenue | 3.8B | 4.1B | 3.9B | 3.9B |
Gross profit | 1.4B | 1.4B | 1.4B | 1.4B |
Operating expense | ||||
Research & development | 112M | — | — | — |
Selling general and admin | 502M | -625M | 924M | 884M |
Other operating expenses | — | — | — | — |
Operating income | 559M | 728M | 495M | 476M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 150M | 161M | 166M | 172M |
Other income expense | 50M | -80M | 101M | 86M |
Pretax income | 459M | 487M | 430M | 390M |
Tax provision | 73M | 31M | 26M | 23M |
Net income | 386M | 456M | 404M | 367M |
Basic EPS | 2.1 | 2.4 | 2.1 | 1.9 |
Diluted EPS | 2.0 | 2.4 | 2.1 | 1.9 |
Basic average shares | 188.5M | 189.7M | 189.6M | 189.7M |
Diluted average shares | 189.1M | 190.6M | 190.5M | 190.6M |
EBITDA | 944M | 974M | 920M | 881M |
Net income from continuing op. | 386M | 456M | 404M | 367M |
Minority interests | 0 | -3M | -4M | -1M |
Preferred stock dividends | — | — | — | — |